Morning light therapy and steady sleep timing for fibromyalgia symptoms
Tests morning light and steadier sleep times in adults with fibromyalgia.
Key facts
- Who runs it
- University of Michigan
- Where
- Ann Arbor, United StatesSee the site
- Trial code
- Registry title
- Fibromyalgia Sleep A to ZZZ Study
- Status
- Recruiting
- People taking part
- 390 people, planned
- Started
- 27 Sept 2024
- Expected to end
- Mar 2029
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Light Therapy
- Sleep Stabilization
- Record updated
- 4 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with fibromyalgia. It tests whether morning light therapy or a fixed sleep schedule changes fibromyalgia symptoms. All visits are by video.
- Age
- 18 Years and older
- Sex
- All sexes
- Disease stage
- Fibromyalgia that meets the 2016 revised diagnostic criteria.
Main reasons for not taking part
- Significant long-term (chronic) disease, or severe hearing or memory problems
- Being pregnant, breastfeeding, or trying to get pregnant
- Night work, or travel outside the eastern time zone within 1 month of the study
- Taking part in other research, or a pending medical leave application at work
- No video calls with camera and sound, or no private space for the remote visits
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Meets 2016 revised diagnostic criteria for fibromyalgia (FM)
- Has access to video conferencing (including web cameras and audio) and a private space for the remote study visits
Who cannot take part
- Significant chronic disease
- Severe hearing or memory problems
- Pending medical leave applications at workplace
- Current pregnancy, breastfeeding, or actively trying to get pregnant
- Night work or travel outside the eastern time zone within 1 month of the study
- Other research participation
- Frequent number of special events during study period (weddings, concerts, exams, etc)
Where in United States
- University of MichiganAnn Arbor, United StatesContact: Helen BurgessTaking people
About the trial
What the trial wants to find out
This research study is testing whether changes in sleep timing and morning light therapy may have an impact on symptoms related to fibromyalgia.
The 3 groups in the trial
- Light TherapyTreatment being tested
All participants will be asked to attend 8 virtual visits over 5 months. Participants randomized to the morning light therapy group are asked to wear the glasses for 1 hour per day. The timing of each person's therapy is tailored to their average wake up time during a baseline period. The treatment period is 4 weeks long.
- Sleep StabilizationTreatment being tested
All participants will be asked to attend 8 virtual visits over 5 months. Participants randomized to the sleep stabilization arm are asked to follow a fixed sleep schedule tailored to their sleep during a baseline period. The treatment period is 4 weeks.
- Control Group, treatment as usualNo study treatment, for comparison
Participants will be asked to sleep as per usual.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- At Home Morning Bright Light Treatment for Chronic Nociplastic Pain
- Plain-language title
- Morning light therapy and steady sleep timing for fibromyalgia symptomsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Publications
- At-Home Morning Bright Light Treatment for Chronic Nociplastic Pain: Protocol for a Randomized Clinical Trial.JMIR research protocols, 2025
- Record updated
- 4 June 2026